BlackRock, Inc. (BLK) 13D/13G Filings for Stoke Therapeutics, Inc. (STOK)

BlackRock, Inc. 13D and 13G filings for Stoke Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-04-16
6:41 pm
Sale		 2025-03-31 13G Stoke Therapeutics, Inc.
STOK		 BLACKROCK INC
BLK		 3,118,934
5.800%		 -2,290,235decrease
(-42.34%)		 Filing
2024-07-08
4:32 pm
Purchase		 2024-06-30 13G Stoke Therapeutics, Inc.
STOK		 BLACKROCK INC
BLK		 5,409,169
10.400%		 5,409,169increase
(New Position)		 Filing